Skip to the page

Data / Drug companies / Gold Bond Co LLC

Gold Bond Co LLC: 10 products in the FDA NDC directory, labeler code 84714

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Gold Bond Co LLC (labeler code 84714) lists 10 products in the FDA National Drug Code Directory, covering 6 finished drugs by generic name. By type: 10 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on March 1, 2026.

The request: Watch Gold Bond Co LLC (FDA labeler code 84714): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
84714
Products in commercial distribution
10
Packages
12
Finished drugs by generic name
6
Prescription products
0
Over the counter products
10
Flagged as original packager
10 of 10 products that carry the flag
Started marketing in the last 12 months
1
Earliest marketing start
December 22, 2014
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Over the counter monograph drugs10100%

Products by type

TypeProductsShare
Over the counter drugs10100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Colloidal oatmeal366
Lidocaine hydrochloride2134
Menthol2263
Salicylic acid1330
Pramoxine hydrochloride, menthol17
Dimethicone and white petrolatum11

Dosage forms

Dosage formProductsShare
Cream770%
Lotion220%
Powder110%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Gold Bond Maximum Strength Foot Pain Relief84714-0427CreamOver the counter monograph drugsMarch 1, 2026
Gold Bond Medicated Pain and Itch Relief84714-0529CreamOver the counter monograph drugsMarch 1, 2023
Gold Bond Psoriasis Relief Medicated Multi-Symptom84714-0413CreamOver the counter monograph drugsAugust 1, 2022
Gold Bond Eczema Relief Medicated Hand Cream84714-0668CreamOver the counter monograph drugsMay 1, 2022
Gold Bond Eczema Relief Medicated Skin Protectant Cream84714-0669CreamOver the counter monograph drugsApril 1, 2022
Gold Bond Diabetics Dry Skin Relief Foot Cream84714-0541CreamOver the counter monograph drugsMarch 1, 2022
Gold Bond Medicated Extra Strength Body84714-0410PowderOver the counter monograph drugsMarch 1, 2021
Gold Bond Medicated Anti-Itch84714-0507LotionOver the counter monograph drugsApril 26, 2016
Gold Bond Extra Strength84714-0641LotionOver the counter monograph drugsMarch 11, 2016
Gold Bond Medicated eczema relief84714-0567CreamOver the counter monograph drugsDecember 22, 2014

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.